Boehringer Ingelheim (Canada) Ltd et al. v Laboratoire Riva Inc.

Call to arrange a consultation

2022

T-193-23

Pending

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,752,437 (linagliptin).

Counsel to:

Laboratoire Riva Inc.

The decision is reported

Partner

Counsel

Associate